From gene to therapy: individually adapted cancer medicine

Stefan Fröhling is Managing Director at NCT Heidelberg and Head of the Translational Medical Oncology Division at the German Cancer Research Center (DKFZ). He works at the interface between clinical patient care in oncology and experimental tumor research. In an interview he talks about the topic "From gene to therapy: individually adapted cancer medicine.
 

» Watch the video on YouTube